The mutagenically separated polymerase chain reaction is a rapid and reliable method for genotyping of the tumour necrosis factor-α promoter polymorphism (−308 G/A)
- 30 June 2002
- journal article
- research article
- Published by Elsevier in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 320 (1-2) , 135-138
- https://doi.org/10.1016/s0009-8981(02)00054-2
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosusArthritis & Rheumatism, 2000
- Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to diseaseJournal of Leukocyte Biology, 1999
- Association between − 308 tumour necrosis factor promoter polymorphism and bronchial hyperreactivity in asthmaClinical and Experimental Allergy, 1999
- Association of TNF2, a TNF-α Promoter Polymorphism, With Septic Shock Susceptibility and MortalityJAMA, 1999
- Genetic Polymorphisms in the Tumor Necrosis Factor Locus Influence Non-Hodgkin's Lymphoma OutcomeBlood, 1998
- CYTOKINE GENE POLYMORPHISM AND HEART TRANSPLANT REJECTION1Transplantation, 1997
- Variation in the TNF-α promoter region associated with susceptibility to cerebral malariaNature, 1994
- Mutagenically separated PCR (MS-PCR): a highly specific one step procedure for easy mutation detectionNucleic Acids Research, 1993
- Single base polymorphism in the human Tumour Necrosis Factor alpha (TNFα) gene detectable by Ncol restriction of PCR productHuman Molecular Genetics, 1992